Sign Up Today and Learn More About Jounce Therapeutics Stock
Invest in or calculate the value of your shares in Jounce Therapeutics or other pre-IPO companies through EquityZen's platform.
Jounce Therapeutics Stock
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
About Jounce Therapeutics Stock
Founded
2013
Total Funding
103M
Industries
Science and Engineering, Health Care, Biotechnology
Jounce Therapeutics Press Mentions
Stay in the know about the latest news on Jounce Therapeutics
A startup trying to get the human body to fight cancer just filed for an IPO
• Jan 04, 2017
A startup trying to get the human body to fight cancer just filed for an IPO
• Jan 03, 2017
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work
• Jan 03, 2017
Jounce Therapuetics registers for a 2017 IPO
• Dec 30, 2016
Future Of Cancer Treatment: Immunotherapy Startups Take Lion’s Share Of Oncology Deals
• Nov 05, 2016
Jounce Therapeutics Management
Leadership team at Jounce Therapeutics
Director of Business Development and Operations
Jason Fuller
Founder
Padmanee Sharma
Join now and verify your accreditation status to gain access to:
- Jounce Therapeutics Current Valuation
- Jounce Therapeutics Stock Price
- Jounce Therapeutics Management
- Available deals in Jounce Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Jounce Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Jounce Therapeutics Revenue and Financials
- Jounce Therapeutics Highlights
- Jounce Therapeutics Business Model
- Jounce Therapeutics Risk Factors
- Jounce Therapeutics Research Report from SACRA Research
Trading Jounce Therapeutics Stock
How to invest in Jounce Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Jounce Therapeutics through EquityZen funds. These investments are made available by existing Jounce Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Jounce Therapeutics stock?
Shareholders can sell their Jounce Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."